Zydus Cadila gets USFDA nod to market 4 generic products

Pharma firm Zydus Cadila today said it has received final approvals from the US health regulator to market four generic products in America.

Source: The Economic Times Healthcare and Biotech News - July 18, 2018 Category: Pharmaceuticals Source Type: news